Exploring NASDAQ:CORT's high growth characteristics.

We've identified CORCEPT THERAPEUTICS INC (NASDAQ:CORT) as a potential breakout candidate based on our stock screener's analysis. This breakout setup pattern suggests that after a strong uptrend, the stock is currently consolidating, potentially signaling a continuation of the trend. Keep an eye on NASDAQ:CORT for further developments.

Deciphering the Technical Picture of NASDAQ:CORT

ChartMill assigns a Technical Rating to every stock. This score, ranging from 0 to 10, is updated daily and is determined by evaluating multiple technical indicators and properties.

Overall CORT gets a technical rating of 7 out of 10. This is due to a consistent overall performance, although we see some doubts in the very recent evolution. In the medium time frame things are still looking good.

• When comparing the yearly performance of all stocks, we notice that CORT is one of the better performing stocks in the market, outperforming 94% of all stocks. We also observe that the gains produced by CORT over the past year are nicely spread over this period.
• CORT is part of the Pharmaceuticals industry. There are 195 other stocks in this industry. CORT outperforms 92% of them.
• CORT is currently trading in the upper part of its 52 week range. The S&P500 Index is also trading in the upper part of its 52 week range, so CORT is performing more or less in line with the market.
• The long term trend is positive and the short term trend is negative. It is probably better to wait until this picture becomes clearer.

Check the latest full technical report of CORT for a complete technical analysis.

How does the Setup look for NASDAQ:CORT

Alongside the Technical Rating, ChartMill assigns a Setup Rating to evaluate the consolidation level of a stock. This rating, ranging from 0 to 10, is updated daily and considers various short-term technical indicators. The current setup rating for NASDAQ:CORT is 8:

CORT has an excellent technical rating and also presents a decent setup pattern. Prices have been consolidating lately and the volatility has been reduced. There is a resistance zone just above the current price starting at 51.67. Right above this resistance zone may be a good entry point. There is a support zone below the current price at 49.84, a Stop Loss order could be placed below this zone.

Looking into the high growth metrics of CORCEPT THERAPEUTICS INC

• With a favorable trend in its quarter-to-quarter (Q2Q) earnings per share (EPS), CORCEPT THERAPEUTICS INC highlights its ability to generate increasing profitability, showcasing a 46.43% growth.
• With consistent quarter-to-quarter (Q2Q) revenue growth of 47.69%, CORCEPT THERAPEUTICS INC exemplifies its ability to generate increased sales and revenue streams. This growth signifies the company's strong business performance and its potential for continued growth.
• With impressive 1-year revenue growth of 39.65%, CORCEPT THERAPEUTICS INC showcases its ability to generate increased sales and revenue. This growth highlights the company's strong customer demand and its effective business strategies.
• The average next Quarter EPS Estimate for CORCEPT THERAPEUTICS INC has experienced a 17.5% change in the last 3 months, reflecting evolving expectations by analysts regarding the company's EPS performance.
• The quarterly earnings of CORCEPT THERAPEUTICS INC have shown a 46.43% increase compared to the previous quarter, as revealed in the recent financial report. This growth signifies positive momentum in the company's financials, pointing towards a promising upward trend
• The earnings per share (EPS) growth of CORCEPT THERAPEUTICS INC are accelerating: the current Q2Q growth of 46.43% is above the previous year Q2Q growth of -6.67%. Earnings momentum and acceleration are key for high growth systems.
• With a favorable trend in its operating margin over the past year, CORCEPT THERAPEUTICS INC demonstrates its ability to enhance profitability through efficient operations. This growth reflects the company's focus on optimizing its cost structure.
• In terms of Return on Equity(ROE), CORCEPT THERAPEUTICS INC is performing well, achieving a 22.2% ratio. This highlights the company's effective allocation of shareholder investments and signifies its commitment to maximizing returns.
• With a Debt-to-Equity ratio at 0.0, CORCEPT THERAPEUTICS INC showcases its prudent financial management. The company's balanced approach between debt and equity reflects its commitment to maintaining a stable capital structure.
• CORCEPT THERAPEUTICS INC has consistently exceeded EPS estimates in the last 4 quarters, demonstrating its ability to outperform market expectations. This trend highlights the company's strong financial performance and its potential for future growth.
• CORCEPT THERAPEUTICS INC has exhibited strong Relative Strength(RS) in recent periods, with a current 94.19 rating. This indicates the stock's ability to outperform the broader market and reflects its competitive position. CORCEPT THERAPEUTICS INC shows promising potential for continued price momentum.

More ideas for high growth momentum breakouts can be found on ChartMill in our High Growth Momentum Breakout screen.

Disclaimer

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.